title: Drug-resistant tuberculosis: pediatric guidelines.
abstract: Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting.
authors.affiliation: Division of Infectious and Immunological Diseases, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: Mona
authors.initials: M
authors.lastname: Al-Dabbagh
authors.forename: Keswadee
authors.initials: K
authors.lastname: Lapphra
authors.forename: Rumi
authors.initials: R
authors.lastname: McGloin
authors.forename: Kelsey
authors.initials: K
authors.lastname: Inrig
authors.forename: H Simon
authors.initials: HS
authors.lastname: Schaaf
authors.forename: Ben J
authors.initials: BJ
authors.lastname: Marais
authors.forename: Laura
authors.initials: L
authors.lastname: Sauve
authors.forename: Ian
authors.initials: I
authors.lastname: Kitai
authors.forename: Tobias R
authors.initials: TR
authors.lastname: Kollmann
mesh_terms: D000293:Adolescent; D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination / Q000379:methods; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification; D010372:Pediatrics / Q000379:methods*; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents